Business Description
Peijia Medical Ltd
ISIN : KYG6981F1090
Share Class Description:
FRA:4WO: Ordinary SharesTotal Employee Number:
1,022Compare
Compare
Traded in other countries / regions
09996.Hong Kong4WO.GermanyPEJMF.USA IPO Date
2020-06-03Description
Peijia Medical Ltdis a provider of inventive medical products and solutions. It focuses on the high-growth interventional procedural medical device market in China. Its products and product candidates target large, fast-growing and under-penetrated markets with high entry barriers, including the transcatheter valve therapeutic medical device market and the neurointerventional procedural medical device market. The Company's product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates spanning three key business segments: Transcatheter Valve Therapeutic Business, Future Technology Business and Neurointerventional Business.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.27 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | -3.54 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -0.39 | |||||
Beneish M-Score | -3.17 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 41.7 | |||||
3-Year EBITDA Growth Rate | 30.1 | |||||
3-Year EPS without NRI Growth Rate | 18.8 | |||||
3-Year FCF Growth Rate | 17.5 | |||||
3-Year Book Growth Rate | -11.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 27.4 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.96 | |||||
9-Day RSI | 46.12 | |||||
14-Day RSI | 43.89 | |||||
3-1 Month Momentum % | -39.72 | |||||
6-1 Month Momentum % | -42.93 | |||||
12-1 Month Momentum % | -43.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.21 | |||||
Quick Ratio | 1 | |||||
Cash Ratio | 0.81 | |||||
Days Inventory | 225.06 | |||||
Days Sales Outstanding | 34.64 | |||||
Days Payable | 181.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -5.55 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 68.17 | |||||
Operating Margin % | -27.44 | |||||
Net Margin % | -28.56 | |||||
EBITDA Margin % | -17.3 | |||||
FCF Margin % | -45.62 | |||||
OCF Margin % | -2.94 | |||||
ROE % | -10.56 | |||||
ROA % | -7.76 | |||||
ROIC % | -9.83 | |||||
3-Year ROIIC % | 42.86 | |||||
ROC (Joel Greenblatt) % | -27.29 | |||||
ROCE % | -9.11 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 555 | |||||
PS Ratio | 3.53 | |||||
PB Ratio | 1.37 | |||||
Price-to-Tangible-Book | 2.34 | |||||
EV-to-EBIT | -12.27 | |||||
EV-to-EBITDA | -19.03 | |||||
EV-to-Revenue | 3.29 | |||||
EV-to-FCF | -7.22 | |||||
Price-to-GF-Value | 0.51 | |||||
Earnings Yield (Greenblatt) % | -8.15 | |||||
FCF Yield % | -12.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Peijia Medical Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 86.258 | ||
| EPS (TTM) (€) | -0.037 | ||
| Beta | 0.2779 | ||
| 3-Year Sharpe Ratio | -0.08 | ||
| 3-Year Sortino Ratio | -0.11 | ||
| Volatility % | 54.53 | ||
| 14-Day RSI | 43.89 | ||
| 14-Day ATR (€) | 0.015041 | ||
| 20-Day SMA (€) | 0.4213 | ||
| 12-1 Month Momentum % | -43.68 | ||
| 52-Week Range (€) | 0.394 - 1.01 | ||
| Shares Outstanding (Mil) | 669.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Peijia Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Peijia Medical Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Peijia Medical Ltd Frequently Asked Questions
What is Peijia Medical Ltd(FRA:4WO)'s stock price today?
The current price of FRA:4WO is €0.42. The 52 week high of FRA:4WO is €1.01 and 52 week low is €0.39.
When is next earnings date of Peijia Medical Ltd(FRA:4WO)?
The next earnings date of Peijia Medical Ltd(FRA:4WO) is .
Does Peijia Medical Ltd(FRA:4WO) pay dividends? If so, how much?
Peijia Medical Ltd(FRA:4WO) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Peijia Medical and HighLife Enter Into License and Technology Transfer Agreement for Transeptal Mitral Valve Replacement in Greater China | 2020-12-20 |
Articles on Peijia Medical Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers